Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Weatherald

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
American Journal of Respiratory and Critical Care Medicine|September 21, 2023
Win Statistics in Pulmonary Arterial Hypertension Clinical TrialsJason Weatherald, Jude Moutchia, Nadine Al-Naamani, et al.
Chest|March 4, 2019
A Prospective Evaluation of the Diagnostic Accuracy of the Physical Examination for Pulmonary HypertensionMichael Braganza, Jeffrey Shaw, Kevin Solverson, et al.
ERJ Open Research|April 26, 2021
Rapid prediction of adverse outcomes for acute normotensive pulmonary embolism: derivation of the Calgary Acute Pulmonary Embolism scoreKevin Solverson, Christopher Humphreys, Zhiying Liang, et al.
Respiratory Medicine|March 10, 2022
The effectiveness of pulmonary rehabilitation for Post-COVID symptoms: A rapid review of the literatureLesley J J Soril, Ronald W Damant, Grace Y Lam, et al.
American Journal of Respiratory and Critical Care Medicine|March 12, 2024
Constructing the Framework for Disease Modification in Pulmonary Arterial HypertensionRoham T Zamanian, Jason Weatherald, Andrew J Sweatt, et al.
ERJ Open Research|November 26, 2025
Drugs and toxins associated with pulmonary arterial hypertension: from established culprits to novel threatsJulien Grynblat, Alex Hlavaty, Laurent Savale, et al.
The European Respiratory Journal|August 29, 2024
Clinical trial design, end-points, and emerging therapies in pulmonary arterial hypertensionJason Weatherald, Thomas R Fleming, Martin R Wilkins, et al.
The European Respiratory Journal|November 28, 2019
Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertensionAthénaïs Boucly, Capucine Morélot-Panzini, Gilles Garcia, et al.
The European Respiratory Journal|June 13, 2020
Pulmonary complications of Bcr-Abl tyrosine kinase inhibitorsJason Weatherald, Louise Bondeelle, Marie-Camille Chaumais, et al.
American Journal of Respiratory and Critical Care Medicine|March 15, 2022
BET Protein Inhibition for Pulmonary Arterial Hypertension: A Pilot Clinical TrialSteeve Provencher, François Potus, Pascale Blais-Lecours, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
American Journal of Respiratory and Critical Care Medicine|September 21, 2023
Win Statistics in Pulmonary Arterial Hypertension Clinical TrialsJason Weatherald, Jude Moutchia, Nadine Al-Naamani, et al.
Chest|March 4, 2019
A Prospective Evaluation of the Diagnostic Accuracy of the Physical Examination for Pulmonary HypertensionMichael Braganza, Jeffrey Shaw, Kevin Solverson, et al.
ERJ Open Research|April 26, 2021
Rapid prediction of adverse outcomes for acute normotensive pulmonary embolism: derivation of the Calgary Acute Pulmonary Embolism scoreKevin Solverson, Christopher Humphreys, Zhiying Liang, et al.
Respiratory Medicine|March 10, 2022
The effectiveness of pulmonary rehabilitation for Post-COVID symptoms: A rapid review of the literatureLesley J J Soril, Ronald W Damant, Grace Y Lam, et al.
American Journal of Respiratory and Critical Care Medicine|March 12, 2024
Constructing the Framework for Disease Modification in Pulmonary Arterial HypertensionRoham T Zamanian, Jason Weatherald, Andrew J Sweatt, et al.
ERJ Open Research|November 26, 2025
Drugs and toxins associated with pulmonary arterial hypertension: from established culprits to novel threatsJulien Grynblat, Alex Hlavaty, Laurent Savale, et al.
The European Respiratory Journal|August 29, 2024
Clinical trial design, end-points, and emerging therapies in pulmonary arterial hypertensionJason Weatherald, Thomas R Fleming, Martin R Wilkins, et al.
The European Respiratory Journal|November 28, 2019
Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertensionAthénaïs Boucly, Capucine Morélot-Panzini, Gilles Garcia, et al.
The European Respiratory Journal|June 13, 2020
Pulmonary complications of Bcr-Abl tyrosine kinase inhibitorsJason Weatherald, Louise Bondeelle, Marie-Camille Chaumais, et al.
American Journal of Respiratory and Critical Care Medicine|March 15, 2022
BET Protein Inhibition for Pulmonary Arterial Hypertension: A Pilot Clinical TrialSteeve Provencher, François Potus, Pascale Blais-Lecours, et al.
Pageof 16